Hygen Pharma TB-500 10mg Vial (Includes 2 Insulin Syringes)

Hygen Pharma TB-500 10mg is a laboratory-grade research peptide commonly studied for its potential role in tissue repair, recovery acceleration, angiogenesis support, and cellular regeneration. TB-500 (Thymosin Beta-4 fragment) has been widely examined in research settings for its influence on muscle recovery, mobility markers, and cellular repair pathways.

Produced under sterile quality-controlled conditions by Hygen Pharma, this formulation is suitable for scientific environments exploring wound healing, soft-tissue regeneration, and inflammation modulation models.

Peptide Profile:

• Compound: TB-500 (Thymosin Beta-4 fragment)
• Form: Injectable vial
• Concentration: 10mg
• Purity: ≥98%
• Research Focus: Tissue repair, recovery acceleration, inflammation modulation, regeneration pathways
• Includes 2 free insulin syringes.

How to Use in Research:

• Suggested research dosing: 2–5mg weekly depending on protocol
• Administration: subcutaneous or intramuscular depending on study design
• Store refrigerated; avoid freezing after reconstitution

Stacking Notes: Frequently researched together with BPC-157, NAD+, or similar regenerative peptides to evaluate potential synergy.

For scientific and laboratory use only — not for human use.